Jason

[Franco WT Cheng @kfranco_c]

How often do patients stay on GAS without clear indications? It happens naturally in complex care, inspiring my new @KIReports paper. We found GAS initiation links to higher peritonitis & mortality risks in PD. https://t.co/TtiqlpanML

[Eric YF Wan @EricWan_HKU]

Our study found that participation in the #Risk Assessment and Management Programme — #Diabetes Mellitus #RAMP-DM is associated with lower 10-year direct public medical costs and better clinical outcomes. These findings support continued investment in structured #multidisciplinary diabetes management within public primary care.

https://t.co/GgyymxQgjx

Our team:
Dr Eric Tang
@IvyMak_HKU
Dr Emily Tse
Dr Esther Yu
@jychenhku
Dr Weng Yee Chin
Dr David Chao
Dr Wendy Tsui
Dr Tony Ha
@CarlosWongHKU
@CindyLan897569
@hkumed
@HKU_FMPC
@HkuPharm
@CSMPR_HKUPharm
#HKU #HKUMed #FMPC #PrimaryCare #HKUPharm #CSMPR #PopulationBasedCohortStudy #RAMPDM #T2DM #Diabetes

[Eric YF Wan @EricWan_HKU]

Our study found that evaluated risk factors were associated with increased relative #mortality risks in younger #CKD patients, reflecting the importance of early management strategies, emphasizing #LDL-C control in younger and #CVD prevention in older CKD patients.

https://t.co/de8EeIsw7x

Our team:
@jiemei0503hk
@yukkam_yau
@kfranco_c
Dr Emily Tse
@sydney_tang
@PTanuseputro
@CindyLan897569
@hkumed
@HKU_FMPC
@HkuPharm
@CSMPR_HKUPharm
#HKU #HKUMed #FMPC #PrimaryCare #HKUPharm #CSMPR #CKD #RiskFactor #CVD

[Eric YF Wan @EricWan_HKU]

Our target trial emulation study on @BJGPOpen found that #HbA1c monitoring intervals can be individualised according to #glycaemic control in #T2DM patients, which may serve as general recommendations for T2DM patients in primary care and a practical approach to long-term management.

https://t.co/MYcTSqt9Rr

Great work by the team:
@Boyuan_WANG_hku
Dr Emily Tse
Dr Shugang Li
Hao Wu
@ChuiCeline
@CindyLan897569
@hkumed
@HKU_FMPC
@HkuPharm
@CSMPR_HKUPharm
#HKU #HKUMed #FMPC #PrimaryCare #HKUPharm #CSMPR #HbA1C #TargetTrialEmulation #T2DM #Diabetes

[Rainee Yang @RaineeYang_HKU]

Our latest study has been published in
@AnnalsofIM. The DOAC group had a higher 1-year risk of stroke than warfarin in Asian AF-MS patients. We also found that rivaroxaban increased the risk of stroke, while non-rivaroxaban DOACs did not.
Full paper: https://t.co/6Nq1kxVJMj

[Celine Chui HKU @ChuiCeline]

Our study shows that integrating #AI -tools like P-CARDIAC into a 3-tier approach—individual, technical, and organizational; to transform #CVD care and patient outcomes! #AIHealth #cardiology
https://t.co/Plsts7s9JV

[Eric YF Wan @EricWan_HKU]

Our @PLOSMedicine study found that #statin use was associated with reduced risks of #CVDs and all-cause #mortality, including those aged over 85 years with #T2DM, without increased risks for muscle-related adverse events and liver dysfunction observed.
https://t.co/dWSOcTxj4U

[Eric YF Wan @EricWan_HKU]

Our paper found greater reduction in continuity of care was associated with increased incidences of #CVD, #kidney failure, and #mortality in #DM patients in Hong Kong during #COVID. Contingency plans for primary care in public health #crises is essential.
https://t.co/qfzG9AM7uW

[Eric YF Wan @EricWan_HKU]

Our @CommsMedicine paper found that patients of minor #ailment service #MAS by #community #pharmacists report high levels of #symptom #resolution, #satisfaction, and #enablement, suggesting MAS may alleviate pressure on higher-cost healthcare services.
https://t.co/YtFKGyEGcc

[Eric YF Wan @EricWan_HKU]

Our interrupted time series analysis on @JournalofNeph illustrates the indirect effect of the #COVID-19 on Chronic Kidney Disease #CKD patients in Hong Kong, as delayed #CVD diagnoses and increased #mortality rate were seen among non-COVID CKD patients.

https://t.co/MH9zY1jGdo

[Eric YF Wan @EricWan_HKU]

Our @Age_and_Ageing paper found that lowering BP of <130/80 mmHg in old and very old patients was associated with better #cardiovascular and #mortality outcomes without increased adverse events, suggesting a lower BP target may be safe for older patients.
https://t.co/6apws5xE5o

[Eric YF Wan @EricWan_HKU]

Our target trial emulation analysis on @NatureComms provides evidence for a BP target of <130/80 mmHg in clinical guidelines for the treatment of adult HT patients in primary care, with a lower risk of HT-related #complications and all-cause #mortality.

https://t.co/FKdSn7pcnx

[Eric YF Wan @EricWan_HKU]

Our @amjmed paper confirms the substantial economic burden of smoking to Hong Kong despite its low #smoking prevalence. Healthcare costs for women and middle-aged smokers are disproportionately higher, and targeted #cessation programs can be a solution.

https://t.co/qMEPhV6nLu

[Xinya Mu @Silvia1536629]

Happy to share my first PhD paper in Pharmacological Research 🎉

Using a Japanese claims database, we found that concomitant use of quetiapine and Bupleuri Radix (Chaihu)-containing formulations was associated with increased risk of acute adverse events.

https://t.co/qy8Stf8HLa

[Celine Chui HKU @ChuiCeline]

P-CARDIAC is highly receptive among clinicians and patients. It shows promise in monitoring cardiovascular health and feasibility in implementing in primary care. #AIHealth #cardiology @NatalieTsie @ChunKaWong @hkumed @hku_son @HkuPharm

https://t.co/SGLV8P5DFF

[Claire Cuiling WEI @clairewei0830]

Our paper on trends in migraine-specific medication consumption across 73 countries is out now in Journal of Headache and Pain, as part of the collection “2026 Early Career Research Mentorship Program”. 🎉
🔗https://t.co/Ya0rqrmuX8

[Celine Chui HKU @ChuiCeline]

Our study on repeated antibiotic prescribing in patients living with dementia. While we found no association with seizure or other neuropsychiatric disorders, repeated antibiotic courses were associated with an increased risk of all-cause hospitalization. https://t.co/MfxoeSOmok

[Eric YF Wan @EricWan_HKU]

Our paper in Diabetes Research and Clinical Practice suggests optimising #lipid monitoring frequency by baseline #LDL‑C levels for primary prevention of #cardiovascular disease #CVD in patients with type 2 #diabetes #T2DM.

https://t.co/DVBfdYd0at

[Eric YF Wan @EricWan_HKU]

Our study in @eClinicalMed covering a follow-up period of over 10 years found that #statin therapy in chronic #kidney disease #CKD patients was associated with a small yet significant decrease in all-cause #mortality and a modest #reno-protective effect.

https://t.co/SlV7L5oa38

[Eric YF Wan @EricWan_HKU]

In our #multinational study in @JInternMed, #statin initiation may be associated with increased risk of incident #MyastheniaGravis #MG during the first 6–12 months, with a greater magnitude of risk elevation for higher intensity of statin therapy.
https://t.co/V0t7QlR9a7